26 related articles for article (PubMed ID: 7697230)
1. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol/Fluticasone Propionate in a Single Inhaler is Superior to Budesonide Alone in Control of Chinese Asthmatic Adults : An Open-Label, Randomised, 6-Week Study.
Zhong NS; Ping ZJ; Humphries MJ; Xin D
Clin Drug Investig; 2004; 24(10):583-92. PubMed ID: 17523720
[TBL] [Abstract][Full Text] [Related]
3. Interactions between corticosteroids and beta2-agonists.
Hancox RJ
Clin Rev Allergy Immunol; 2006; 31(2-3):231-46. PubMed ID: 17085796
[TBL] [Abstract][Full Text] [Related]
4. Severe asthma.
Kenyon NJ; Jarjour NN
Clin Rev Allergy Immunol; 2003 Oct; 25(2):131-49. PubMed ID: 14573881
[TBL] [Abstract][Full Text] [Related]
5. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts.
Spoelstra FM; Postma DS; Hovenga H; Noordhoek JA; Kauffman HF
Thorax; 2002 Mar; 57(3):237-41. PubMed ID: 11867828
[TBL] [Abstract][Full Text] [Related]
6. Adolescent treatment compliance in asthma.
Dinwiddie R; Müller WG
J R Soc Med; 2002 Feb; 95(2):68-71. PubMed ID: 11823547
[No Abstract] [Full Text] [Related]
7. Interactions between corticosteroids and beta agonists.
Taylor DR; Hancox RJ
Thorax; 2000 Jul; 55(7):595-602. PubMed ID: 10856321
[No Abstract] [Full Text] [Related]
8. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
9. Budesonide. An appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in asthma.
Davis R; McTavish D
Pharmacoeconomics; 1995 May; 7(5):457-70. PubMed ID: 10172461
[TBL] [Abstract][Full Text] [Related]
10. Rational drug strategy in bronchial asthma.
Tan WC
Ann Acad Med Singap; 1991 Jan; 20(1):165-71. PubMed ID: 2029157
[TBL] [Abstract][Full Text] [Related]
11. Use of a fixed combination beta 2-agonist and steroid dry powder inhaler in asthma.
Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1995 Apr; 151(4):1053-7. PubMed ID: 7697230
[TBL] [Abstract][Full Text] [Related]
12. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
13. Effect of regular terbutaline on the airway response to inhaled budesonide.
Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE
Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598
[TBL] [Abstract][Full Text] [Related]
14. Long term clinical comparison of single versus twice daily administration of inhaled budesonide in moderate asthma.
Weiner P; Weiner M; Azgad Y
Thorax; 1995 Dec; 50(12):1270-3. PubMed ID: 8553300
[TBL] [Abstract][Full Text] [Related]
15. Effects of treatment with formoterol on bronchoprotection against methacholine.
Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
